MedTrace Logo

A Post-Market Assessment of the Safety and Performance of the TriClip™ System

NCT07586995 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-05-14

No results posted yet for this study

Summary

The objective of the TREAT TR study is to confirm the safety and performance of the TriClip System for tricuspid TEER in a contemporary, real-world setting, using the commercially available device in accordance with its approved indications for use.

Conditions

  • Tricuspid Regurgitation (TR)

Interventions

DEVICE

Tricuspid Transcatheter Edge-to-Edge Repair (TEER)

TriClip System

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Meghan Griffin · Abbott

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2028-09-30
Completion
2033-08-31
FDA Device
Yes

Countries

  • United States
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07586995 on ClinicalTrials.gov